Hosted on MSN25m
Eli Lilly to Acquire Scorpion Therapeutics' Breast Cancer Candidate For up to $2.5 BillionEli Lilly (LLY) agreed to acquire an experimental treatment for breast cancer and other advanced solid tumors from Scorpion Therapeutics for up to $2.5 billion. The purchase price includes an upfront ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback